Source: GlobeNewswire

Press Release: Paratek : Paratek Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019

BOSTON, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today announced the Company will host a conference call and live audio webcast on Tuesday, November 12, 2019 at 4:30 p.m. EDT to report its financial results for the quarter ended September 30, 2019 and provide a corporate update.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Evan Loh's photo - CEO of Paratek


Evan Loh

CEO Approval Rating


Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Read more